(22597) A study to learn about how safe nitroglycerin is and how it affects the body when taken along with nurandociguat in people with coronary artery disease.
22597
Phase 1 other active
Quick answer
(22597) A study to learn about how safe nitroglycerin is and how it affects the body when taken along with nurandociguat in people with coronary artery disease. for Chronic kidney disease, Coronary artery disease is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Chronic kidney disease, Coronary artery disease
- Phase
- Phase 1
- Modality
- other
- Status
- active